Study Funding AgreementStudy Funding Agreement • May 15th, 2003 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances) • Delaware
This Study Funding Agreement, dated as of April 23, 2003, is made by and between Targeted Genetics Corporation, a corporation organized and existing under the laws of the State of Washington, having offices located at 1100 Olive Way, Suite 100, Seattle, Washington 98101 (“TG”), and Cystic Fibrosis Foundation Therapeutics, Inc., a not for profit corporation organized and existing under the laws of the State of Delaware, having offices located at 6931 Arlington Road, Bethesda, Maryland 20814 (“CFFT”) with respect to Study Protocol and involving the Compound, both as defined below.
BIOLOGICAL PROCESSING SERVICES AGREEMENTBiological Processing Services Agreement • May 15th, 2003 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances) • Maryland
This BIOLOGICAL PROCESSING SERVICES AGREEMENT (“Agreement”) is made effective as of March 28, 2003 (“Effective Date”) by and between GenVec, Inc. (“GenVec”), having its principal place of business at 65 West Watkins Mill Road, Gaithersburg, Maryland 20878, and Targeted Genetics Corporation (“Targeted Genetics”), having its principal place of business at 1100 Olive Way, Suite 100, Seattle, Washington 98101.
